Oral Spray Treatment Better Than Imitrex, Says NovaDel
Posted on: Friday, 29 September 2006, 12:00 CDT
NovaDel Pharma has said that trials of its sumatriptan oral spray for migraines showed the treatment performed better than GlaxoSmithKline's drug, Imitrex.
NovaDel said that a pharmacokinetic study of its improved oral spray formulation of sumatriptan demonstrated positive results. Sumatriptan is the active ingredient in GlaxoSmithKline's leading migraine remedy, Imitrex.
Results from this pilot study demonstrate that sumatriptan oral spray achieves a statistically significant faster rate of absorption than Imitrex tablets. The rate of drug absorption is believed to be the most important predictor of the degree and speed of migraine relief.
"Migraine sufferers want rapid, effective and predictable relief and many experience nausea and vomiting during attacks making tablets difficult to take. We therefore believe our sumatriptan oral spray could provide migraine sufferers with a new, improved therapeutic alternative," commented Jan Egberts, president and CEO of NovaDel.
Based on these positive findings NovaDel plans to complete the pivotal pharmacokinetic program in 2007 to support a new drug application.
Source: Datamonitor
Related Articles
- OraSure's Intercept Oral Fluid Drug Test Results Comparable to Urine Drug Screening According to Landmark Five-Year Analysis
- Celgene Wins Marketing Approval for Oral Myeloma Drug in Canada
- Biocon Reports Encouraging Results From Oral Diabetes Drug Study
- NICE Recommends Against GSK's Oral Cancer Drug
- A Weight Neutral Oral Antidiabetic Drug Would Earn a 25 Percent Patient Share in the Type 2 Diabetes Drug Market
- Hadasit, Hadassah Medical Organization and Brigham and Women's Hospital Announce the Successful Phase I Study Results of a New Orally Administered Drug for Autoimmune Diseases
- Yissum Reports Discovery of Oral Anticancer Drug
- Roche's Oral Cancer Drug Effective Over Intravenous Chemotherapy
- Oral Cancer Drug Revlimid Gets Swissmedic Approval
- CollaGenex OK'D on Oral Rosacea Drug
 |
 |
User Comments (0)
RSS Feeds